Literature DB >> 23892487

Composition and properties of silver-containing calcium carbonate-calcium phosphate bone cement.

Sylvaine Jacquart1, Robin Siadous, Christel Henocq-Pigasse, Reine Bareille, Christine Roques, Christian Rey, Christèle Combes.   

Abstract

The introduction of silver, either in the liquid phase (as silver nitrate solution: Ag(L)) or in the solid phase (as silver phosphate salt: Ag(S)) of calcium carbonate-calcium phosphate (CaCO3-CaP) bone cement, its influence on the composition of the set cement (C-Ag(L) and C-Ag(S) cements with a Ca/Ag atomic ratio equal to 10.3) and its biological properties were investigated. The fine characterisation of the chemical setting of silver-doped and reference cements was performed using FTIR spectroscopy. We showed that the formation of apatite was enhanced from the first hours of maturation of C-Ag(L) cement in comparison with the reference cement, whereas a longer period of maturation (about 10 h) was required to observe this increase for C-Ag(S) cement, although in both cases, silver was present in the set cements mainly as silver phosphate. The role of silver nitrate on the setting chemical reaction is discussed and a chemical scheme is proposed. Antibacterial activity tests (S. aureus and S. epidermidis) and in vitro cytotoxicity tests (human bone marrow stromal cells (HBMSC)) showed that silver-loaded CaCO3-CaP cements had antibacterial properties (anti-adhesion and anti-biofilm formation) without a toxic effect on HBMSC cells, making C-Ag(S) cement a promising candidate for the prevention of bone implant-associated infections.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23892487     DOI: 10.1007/s10856-013-5014-2

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  28 in total

Review 1.  Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often?

Authors:  J Ciampolini; K G Harding
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

2.  In vitro elution of vancomycin from calcium phosphate cement.

Authors:  Tomoyuki Sasaki; Yasuyuki Ishibashi; Hiroshi Katano; Akira Nagumo; Satoshi Toh
Journal:  J Arthroplasty       Date:  2005-12       Impact factor: 4.757

3.  Comparing the efficacy of three bioceramic matrices for the release of vancomycin hydrochloride.

Authors:  Peih-Jeng Jiang; Sarika Patel; Uwe Gbureck; Ryan Caley; Liam M Grover
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2010-04       Impact factor: 3.368

4.  Risk factors for prosthetic joint infection: case-control study.

Authors:  E F Berbari; A D Hanssen; M C Duffy; J M Steckelberg; D M Ilstrup; W S Harmsen; D R Osmon
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

5.  Effect of silver content on the antibacterial and bioactive properties of silver-substituted hydroxyapatite.

Authors:  Poon Nian Lim; Erin Yiling Teo; Bow Ho; Bee Yen Tay; Eng San Thian
Journal:  J Biomed Mater Res A       Date:  2013-01-24       Impact factor: 4.396

6.  Antimicrobial effects of metal ions (Ag+, Cu2+, Zn2+) in hydroxyapatite.

Authors:  T N Kim; Q L Feng; J O Kim; J Wu; H Wang; G C Chen; F Z Cui
Journal:  J Mater Sci Mater Med       Date:  1998-03       Impact factor: 3.896

7.  Silver polymethyl methacrylate antibacterial bone cement.

Authors:  J A Spadaro; D A Webster; R O Becker
Journal:  Clin Orthop Relat Res       Date:  1979-09       Impact factor: 4.176

8.  An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement.

Authors:  Volker Alt; Thorsten Bechert; Peter Steinrücke; Michael Wagener; Peter Seidel; Elvira Dingeldein; Eugen Domann; Reinhard Schnettler
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

9.  Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo.

Authors:  U Joosten; A Joist; T Frebel; B Brandt; S Diederichs; C von Eiff
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

10.  Functionalizing calcium phosphate biomaterials with antibacterial silver particles.

Authors:  Jae Sung Lee; William L Murphy
Journal:  Adv Mater       Date:  2012-11-26       Impact factor: 30.849

View more
  3 in total

1.  Influence of the Microstructure and Silver Content on Degradation, Cytocompatibility, and Antibacterial Properties of Magnesium-Silver Alloys In Vitro.

Authors:  Zhidan Liu; Ronald Schade; Bérengère Luthringer; Norbert Hort; Holger Rothe; Sören Müller; Klaus Liefeith; Regine Willumeit-Römer; Frank Feyerabend
Journal:  Oxid Med Cell Longev       Date:  2017-06-22       Impact factor: 6.543

2.  Nanoapatites Doped and Co-Doped with Noble Metal Ions as Modern Antibiofilm Materials for Biomedical Applications against Drug-Resistant Clinical Strains of Enterococcus faecalis VRE and Staphylococcus aureus MRSA.

Authors:  Emil Paluch; Paulina Sobierajska; Piotr Okińczyc; Jarosław Widelski; Anna Duda-Madej; Barbara Krzyżanowska; Paweł Krzyżek; Rafał Ogórek; Jakub Szperlik; Jacek Chmielowiec; Grażyna Gościniak; Rafal J Wiglusz
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

Review 3.  Is Silver the New Gold? A Systematic Review of the Preclinical Evidence of Its Use in Bone Substitutes as Antiseptic.

Authors:  Michele Fiore; Alessandro Bruschi; Claudio Giannini; Lorenzo Morante; Claudia Rondinella; Matteo Filippini; Andrea Sambri; Massimiliano De Paolis
Journal:  Antibiotics (Basel)       Date:  2022-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.